Stock Research: Apex Biotechnology

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Apex Biotechnology

TAI:1733 TW0001733004
86
  • Value
    61
  • Growth
    33
  • Safety
    Safety
    85
  • Combined
    73
  • Sentiment
    82
  • 360° View
    360° View
    86
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

APEX BIOTECHNOLOGY CORP develops, manufactures, and distributes testing strips and monitoring systems. The company operates in the medical devices and diagnostics industries. It primarily serves markets in the Americas, Europe, and Asia. In the last fiscal year, the company had a market cap of $93 million, profits of $16 million, and revenue of $56 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
61 45 66 77
Growth
33 8 47 45
Safety
Safety
85 58 65 37
Sentiment
82 93 93 68
360° View
360° View
86 44 96 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
15 15 18 18
Opinions Change
50 50 50 50
Pro Holdings
n/a 76 100 85
Market Pulse
100 100 100 100
Sentiment
82 93 93 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
61 45 66 77
Growth
33 8 47 45
Safety Safety
85 58 65 37
Combined
73 20 63 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
58 60 59 74
Price vs. Earnings (P/E)
51 20 39 56
Price vs. Book (P/B)
52 40 45 64
Dividend Yield
83 89 97 99
Value
61 45 66 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
65 1 61 19
Profit Growth
55 27 43 31
Capital Growth
36 19 15 52
Stock Returns
27 49 85 93
Growth
33 8 47 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
74 59 59 36
Refinancing
88 60 65 69
Liquidity
70 44 55 30
Safety Safety
85 58 65 37

Similar Stocks

Discover high‑ranked alternatives to Apex Biotechnology and broaden your portfolio horizons.

CTBC Financial Holding

TAI:2891
Country: Taiwan
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Galaxy Entertainment

HKG:27
Country: Hong Kong
Industry: Casinos & Gaming
Size: X-Large
Full Stock Analysis

Subaru

TYO:7270
Country: Japan
Industry: Automobile Manufacturers
Size: X-Large
Full Stock Analysis

Wistron

TAI:3231
Country: Taiwan
Industry: Technology Hardware & Peripherals
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: